Examples of using Concomitant use in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
To be taken into account with concomitant use Others.
Post-marketing reports: following the concomitant use of spinosad with ivermectin indicate that dogs.
Concomitant use of medicines for erectile dysfunction
The concomitant use of ecstasy and antidepressants is associated with serious health risks.
There is no experience regarding the withdrawal of concomitant use of anti-epileptic medicinal products during treatment with Exalief switch to monotherapy.
There is no experience regarding the withdrawal of concomitant use of anti-epileptic medicinal products during treatment with Zebinix i.e. switching to monotherapy.
accentuate cardiac arrhythmias associated with the concomitant use of digitalis glycosides or certain anti-arrhythmic medicinal products.
Concomitant use of bosentan and darunavir co-administered with low dose ritonavir may increase plasma concentrations of bosentan.
The concomitant use of ribavirin with zidovudine is not recommended due to an increased risk of anaemia see section 4.4.
Concomitant use of TOBI Podhaler with diuretic compounds(such as ethacrynic acid,
Concomitant use with aliskiren-containing medicinal products in patients with diabetes mellitus
Post marketing cases of peripheral oedema and cardiac failure have also been reported in patients with concomitant use of pioglitazone and nonsteroidal anti- inflammatory drugs, including selective COX-2 inhibitors.
Concomitant use of a selective MAO-A inhibitor
it should be used with caution in case of concomitant use of medicinal products influenced by hepatic enzyme.
In the case of concomitant use with other active substances refer to sections 4.4
As a precaution concomitant use of medicinal products that inhibit CYP2C19 should be discouraged see section 4.5 for a list of CYP2C19 inhibitors, see also section 5.2.
As a precaution concomitant use of medicinal products that inhibit CYP2C19 should be discouraged see sections 4.4 and 5.2.
As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged see section 4.5 for a list of CYP2C19 inhibitors, see also section 5.2.
As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged see sections 4.4 and 5.2.
As a precaution concomitant use of strong or moderateCYP2C19 inhibitors should be discouraged see sections 4.4 and 5.2.